Adjunctive phage therapy improves antibiotic treatment of Ventilator-Associated-Pneumonia with Pseudomonas aeruginosa

Chantal Weissfuss(Humboldt-Universität zu Berlin), Geraldine Nouailles(Humboldt-Universität zu Berlin), Ulrike Behrendt(Humboldt-Universität zu Berlin), Magdalena Bürkle(Humboldt-Universität zu Berlin), Baptiste Gaborieau(Centre National de la Recherche Scientifique), Laurent Debarbieux(House of Representatives), Christine H. Rohde(Columbia University Irving Medical Center), Imke H. E. Korf(Fraunhofer Institute for Toxicology and Experimental Medicine), Karen Hoffmann(Humboldt-Universität zu Berlin), Gopinath Krishnamoorthy(Humboldt-Universität zu Berlin), Martin Witzenrath(Humboldt-Universität zu Berlin), Matthias Felten(Humboldt-Universität zu Berlin), Jingjing Li(University of Pennsylvania), Jean-Damien Ricard(Inserm)
Research Square
September 26, 2024
10.21203/rs.3.rs-5017709/v1
Cited by 1

Related Papers

Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19
|JAMA|2020|518
The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guideline
|Intensive Care Medicine|2020|413
Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage
|Science|2020|382
Effect of Postextubation High-Flow Nasal Oxygen With Noninvasive Ventilation vs High-Flow Nasal Oxygen Alone on Reintubation Among Patients at High Risk of Extubation Failure
|JAMA|2019|353
The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?
|Pharmaceutical Research|2010|298